Dr. Ivan Cornella-Taracido, of Cedilla Therapeutics, discusses his work looking for therapeutic targets by harnessing protein homeostasis, and shares his insights into the future of drug discovery
An expert cellular biologist answers your questions on cell subset identification in studying heterogeneous populations of cells
Applications now open for the Eppendorf Award for Young European Investigators
AutoScratch tool to facilitate 2D collective cell migration and invasion applications
Attend this free webinar to discover new imaging technology that enables true 3D high content analysis
Discover the dedicated sessions on offer for early careers professionals at ELRIG Drug Discovery 2018
Your solution for quick and easy filtration of single-cell suspensions
Discover a comprehensive guide to real-time live-cell imaging and analysis
Ready-to-use immunoassay kit designed to increase productivity
Researchers reveal new insights into self repair pathways in cancer cells, after therapy with PARP inhibitors
Discover how scientists in Sweden and Finland are developing a functional systems precision medicine strategy to optimize treatment of acute myeloid leukemia
New 3D model provides options for drug development and treatment of gestational disorders
World-renowned laboratories’ workflow and performance studies succeeded in KPIs such as turnaround time, throughput, hands-on system time, and assay performance
The findings could help clinicians decide the best course and delivery of treatment for cancer patients
A laboratory in the US is using advanced imaging to decipher the role of a ‘double-agent’ protein in breast cancer, and to help develop drugs targeted at disrupting its function
CRISPR-Cas9 found to induce p53 expression in cells
The Oncomine TCR Beta-SR Assay for next-generation sequencing enables site-specific interrogation for T-cell receptor applications
Learn about the essential and upcoming technologies for target biology in this interview with Andrea Faedo, Head of Innovative Tools&Solutions at Axxam S.p.A.
Understanding the impact and management of these metals could lead to more effective future therapies for Alzheimer’s
